Table 3.
Baseline subject characteristics.
| Measure | Unit | Males (n = 15) | Females (n = 15) | ||
|---|---|---|---|---|---|
| Mean | SEM † | Mean | SEM ‡ | ||
| Age | years | 25.3 | 2.8 | 24.8 | 2.2 |
| Weight | kg | 74.8 | 10.1 | 58.3 | 7.7 *** |
| Height | cm | 175.0 | 4.0 | 164.0 | 4.4 *** |
| BMI | kg/m2 | 24.3 | 2.9 | 21.7 | 2.7 * |
| Glucose | mmol/L | 5.4 | 0.6 | 5.0 | 0.4 ** |
| Insulin | μU/mL | 7.3 | 0.8 | 7.9 | 0.4 |
| HOMA-IR | 1.8 | 1.3 | 1.7 | 0.6 | |
† Values presented as means ± SEM from fasting samples collected on all three occasions; ‡ Main effects and interactions were analysed by two-factor repeated-measures ANOVA (treatment and sex) with Sidak corrected post hoc tests. There were no differences between group baseline values between treatment days; * p < 0.05, ** p < 0.01, *** p < 0.001 compared with male subjects.